NURIX THERAPEUTICS, INC. (NRIX) Capital expenditures 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$14.0MFY2025 · since FY2019: $1.7M → $14.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $14.0M | +51.0% |
| FY2024 | $9.3M | +10.4% |
| FY2023 | $8.4M | -31.4% |
| FY2022 | $12.2M | +116.3% |
| FY2021 | $5.7M | +24.3% |
| FY2020 | $4.6M | +175.8% |
| FY2019 | $1.7M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice